vimarsana.com

Latest Breaking News On - Mannin research - Page 1 : vimarsana.com

Q BioMed Inc Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe

Q BioMed Inc boosted by multi-million dollar asset as it converts long-term royalty into equity stake in Mannin Research

Q BioMed Inc has given itself a big shot in the arm, adding a multi-million dollar asset in the form of an equity stake in long term partner Mannin.

Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC

Navigo and Mannin agree to develop a novel drug for treating COVID-19

Precision X affinity ligand will enable the efficient purification of the non-Fc fusion protein - News - PharmaTimes

Financial Review: Q BioMed (OTCMKTS:QBIO) vs Indaptus Therapeutics (NASDAQ:INDP)

Q BioMed (OTCMKTS:QBIO – Get Rating) and Indaptus Therapeutics (NASDAQ:INDP – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Q BioMed and Indaptus Therapeutics’ […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.